Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/113647
Title: Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study
Author: Dierssen-Sotos, Trinidad
Gómez-Acebo, Inés
Pedro, María de
Pérez-Gómez, Beatriz
Servitja, Sonia
Moreno Aguado, Víctor
Amiano, Pilar
Fernandez Villa, Tania
Barricarte, Aurelio
Tardón, Adonina
Diaz-Santos, Marian
Peiró, Rosana
Marcos-Gragera, Rafael
Lope, Virginia
Gracia-Lavedan, Esther
Henar Alonso, M.
Michelena-Echeveste, Maria Jesus
Garcia-Palomo, Andrés
Guevara, Marcela
Castaño-Vinyals, Gemma
Aragonés, Nuria
Kogevinas, Manolis
Pollán, Marina
Llorca Díaz, Javier
Keywords: Càncer de mama
Antiinflamatoris no esteroïdals
Estudi de casos
Breast cancer
Nonsteroidal anti-inflammatory agents
Case studies
Issue Date: 20-Aug-2016
Publisher: BioMed Central
Abstract: Background: The relationship between non-steroidal anti-inflammatory drug (NSAID) consumption and breast cancer has been repeatedly studied, although the results remain controversial. Most case-control studies reported that NSAID consumption protected against breast cancer, while most cohort studies did not find this effect. Most studies have dealt with NSAIDs as a whole group or with specific drugs, such aspirin, ibuprofen, or others, but not with NSAID subgroups according to the Anatomical Therapeutic Chemical Classification System; moreover, scarce attention has been paid to their effect on different tumor categories (i.e.: ductal/non-ductal, stage at diagnosis or presence of hormonal receptors). Methods: In this case-control study, we report the NSAID - breast cancer relationship in 1736 breast cancer cases and 1895 healthy controls; results are reported stratifying by the women's characteristics (i.e.: menopausal status or body mass index category) and by tumor characteristics. Results: In our study, NSAID use was associated with a 24 % reduction in breast cancer risk (Odds ratio [OR] = 0.76; 95 % Confidence Interval [CI]: 0.64-0.89), and similar results were found for acetic acid derivatives, propionic acid derivatives and COXIBs, but not for aspirin. Similar results were found in postmenopausal and premenopausal women. NSAID consumption also protected against hormone + or HER2+ cancers, but not against triple negative breast cancers. The COX-2 selectivity showed an inverse association with breast cancer (i.e. OR < 1), except in advanced clinical stage and triple negative cancers. Conclusion: Most NSAIDs, but not aspirin, showed an inverse association against breast cancer; this effect seems to be restricted to hormone + or HER2+ cancers.
Note: Reproducció del document publicat a: https://doi.org/10.1186/s12885-016-2692-4
It is part of: BMC Cancer, 2016, vol. 16, p. 660
Related resource: https://doi.org/10.1186/s12885-016-2692-4
URI: http://hdl.handle.net/2445/113647
ISSN: 1471-2407
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
665136.pdf463.16 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons